CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer

NCT03829111 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Advanced Renal Cell Carcinoma
Clear Cell Renal Cell Carcinoma
Metastatic Renal Cell Carcinoma
Stage III Renal Cell Cancer AJCC v8
Stage IV Renal Cell Cancer AJCC v8
Unresectable Renal Cell Carcinoma

Interventions

DRUG: Clostridium butyricum CBM 588 Probiotic Strain
BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab

Sponsor

City of Hope Medical Center

Collaborators

[object Object]